Skip to main content

Table 5 Known-group validity for DMQoL compared with that of WHOQOL-BREF

From: Development of diabetes-specific quality of life module to be in conjunction with the World Health Organization quality of life scale brief version (WHOQOL-BREF)

  

Q1a

Q2a

Physicala

Psychologicala

Sociala

Environmenta

Total scorea

DMQoL

  

Mean ± SD

Mean ± SD

Mean ± SD

Mean ± SD

Mean ± SD

Mean ± SD

Mean ± SD

Mean ± SD

CCD

Yes (n = 16)

3.38 ± 0.89

2.81 ± 0.91

10.59 ± 2.11*

 11.92 ± 1.93*

11.33 ± 3.11

13.83 ± 1.82

47.69 ± 6.43*

3.50 ± 0.37

No (n = 75)

3.52 ± 0.70

3.01 ± 0.86

12.23 ± 1.67*

13.09 ± 1.89*

12.74 ± 3.44

14.60 ± 1.75

52.68 ± 6.64*

3.46 ± 0.51

PVD

Yes (n = 4)

3.50 ± 0.58

3.49 ± 0.75

10.71 ± 2.40

12.67 ± 2.11

11.50 ± 4.51

13.67 ± 2.22

48.55 ± 10.32

3.78 ± 0.40

No (n = 87)

3.25 ± 0.96

2.97 ± 0.87

12.01 ± 1.81

12.90 ± 1.94

12.55 ± 3.38

14.50 ± 1.76

51.99 ± 6.68

3.45 ± 0.49

Retinopathy

Yes (n = 16)

3.44 ± 0.73

2.81 ± 0.91

11.86 ± 2.00

13.00 ± 1.46

11.06 ± 5.41

14.86 ± 1.56

50.78 ± 7.44

3.44 ± 0.56

No (n = 75)

3.51 ± 0.74

3.01 ± 0.86

11.98 ± 1.82

12.86 ± 2.03

12.82 ± 2.75

14.38 ± 1.82

52.07 ± 6.73

3.47 ± 0.47

Nephropathy

Yes (n = 34)

3.41 ± 0.70

2.82 ± 0.90

11.88 ± 2.02

12.86 ± 2.00

12.44 ± 3.60

14.54 ± 1.70

51.72 ± 7.10

3.52 ± 0.51

No (n = 57)

3.54 ± 0.76

3.07 ± 0.84

12.00 ± 1.74

12.90 ± 1.92

12.55 ± 3.32

14.42 ± 1.83

51.90 ± 6.73

3.43 ± 0.47

CKD stages 3–5, eGFR <60

Yes (n = 11)

3.64 ± 0.67

2.55 ± 0.93

12.21 ± 2.17

12.30 ± 2.21

12.27 ± 3.52

14.83 ± 1.77

58.36 ± 4.77

3.61 ± 0.50

No (n = 80)

3.48 ± 0.75

3.04 ± 0.85

11.92 ± 1.80

12.97 ± 1.90

12.54 ± 3.41

14.41 ± 1.78

57.23 ± 7.36

3.45 ± 0.48

Neuropathy

Yes (n = 10)

3.50 ± 0.53

3.30 ± 0.82

11.14 ± 1.69

12.27 ± 2.02

10.80 ± 3.33

14.13 ± 2.22

48.34 ± 6.62

3.40 ± 0.68

No (n = 81)

3.49 ± 0.76

2.94 ± 0.87

12.06 ± 1.84

12.96 ± 1.92

12.72 ± 3.38

14.50 ± 1.73

52.28 ± 6.77

3.47 ± 0.46

HbA1c

≤ 7% (n = 38)

3.58 ± 0.68

3.26 ± 0.86

11.85 ± 2.40

13.05 ± 2.37

12.49 ± 2.81

14.27 ± 1.94

51.67 ± 7.48

3.66 ± 0.47*

> 8% (n = 32)

3.34 ± 0.75

3.00 ± 0.95

12.46 ± 2.08

13.10 ± 2.16

12.94 ± 3.80

14.83 ± 1.77

53.34 ± 7.77

3.41 ± 0.53*

Cholesterol

≤ 200 mg/dl (n = 101)

3.55 ± 0.76

3.06 ± 0.91

12.55 ± 2.33

13.33 ± 2.19

12.86 ± 3.21

14.84 ± 1.77

53.62 ± 7.44

3.58 ± 0.52 #

>200 mg/dl (n = 13)

3.54 ± 0.88

3.15 ± 0.80

12.57 ± 1.19

12.97 ± 2.17

13.25 ± 3.70

13.91 ± 1.86

52.77 ± 8.14

3.29 ± 0.47 #

  1. *p < 0.05; # p < 0.06 CCD cerebral and cardiovascular diseases, PVD peripheral vascular diseases, CKD chronic kidney diseases; aFrom WHOQOL-BREF